United States Biotechnology & Medical Research

KALA BIO Inc (KALA)

Track

Ticker: KALA Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for KALA BIO Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Proposed sale 17 Mar 2026
Value US$1,939,292.63 | Price 396.11 | Shares 12,574
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-17 2026-03-17 PrS Proposed sale
ANDREW I KOVEN

Director

Non-Executive Director
12,574
396.11
US$1,939,293 		12,574 396.11 US$1,939,293
2026-03-12 2026-03-12 PrS Proposed sale
1.5
Howard B Rosen

Director

Non-Executive Director
32,444
346.90
US$2,573,304 		32,444 346.90 US$2,573,304
2026-03-12 2026-03-12 PrS Proposed sale
3.3
CHARLES D MYERS

Director

Non-Executive Director
77,708
315.97
US$3,185,250 		77,708 315.97 US$3,185,250
2025-10-24 2025-10-23 S Sale
3.3
Iwicki Mark T
Non-Executive Director
154,894 -59.9%
0.81
US$125,464 		154,894 -59.9% 0.81 US$125,464
2025-10-24 2025-10-23 S Sale
3.6
Reumuth Mary

CHIEF FINANCIAL OFFICER

Officer
967 -3.2%
0.82
US$793 		967 -3.2% 0.82 US$793
2025-10-23 2025-10-23 PrS Proposed sale
3.3
MARK IWICKI

Director

Non-Executive Director
154,894
0.81
US$125,185 		154,894 0.81 US$125,185
2025-10-23 2025-10-23 PrS Proposed sale
3.6
MARY REUMUTH

Officer

Officer
967
0.82
US$793 		967 0.82 US$793
2025-10-24 2025-10-22 S Sale
2.3
Bazemore Todd
Non-Executive Director
47,768 -57.1%
0.83
US$39,647 		47,768 -57.1% 0.83 US$39,647
2025-10-24 2025-10-22 S Sale
3.3
Kharabi Darius

CHIEF BUSINESS OFFICER

Officer
20,806 -33.3%
0.83
US$17,269 		20,806 -33.3% 0.83 US$17,269
2025-10-24 2025-10-22 S Sale
3.3
Brazzell Romulus K

SEE REMARKS

Officer
46,748 -56.5%
0.83
US$38,801 		46,748 -56.5% 0.83 US$38,801
2025-10-24 2025-10-22 S Sale
3.6
Reumuth Mary

CHIEF FINANCIAL OFFICER

Officer
32,230 -51.9%
0.83
US$26,751 		32,230 -51.9% 0.83 US$26,751
2025-10-22 2025-10-22 PrS Proposed sale
3.6
MARY REUMUTH

Officer

Officer
32,230
0.83
US$26,728 		32,230 0.83 US$26,728
2025-10-22 2025-10-22 PrS Proposed sale
3.3
R K BRAZZELL

Officer

Officer
46,748
0.83
US$38,964 		46,748 0.83 US$38,964
2025-10-22 2025-10-22 PrS Proposed sale
2.3
TODD M BAZEMORE

Officer

Officer
47,768
0.83
US$39,686 		47,768 0.83 US$39,686
2025-10-22 2025-10-22 PrS Proposed sale
3.3
DARIUS KHARABI

Officer

Officer
20,806
0.83
US$17,284 		20,806 0.83 US$17,284
2025-10-02 2025-10-01 S Sale
3.3
BAKER BROS. ADVISORS LP

Former 10% owner
462,967 -52.1%
1.38
US$640,654 		462,967 -52.1% 1.38 US$640,654
2025-10-02 2025-10-01 S Sale
3.3
BAKER BROS. ADVISORS LP

Former 10% owner
50,640 -52.1%
1.38
US$70,076 		50,640 -52.1% 1.38 US$70,076
2025-10-02 2025-09-30 S Sale
3.3
BAKER BROS. ADVISORS LP

Former 10% owner
195,425 -18.0%
1.60
US$311,879 		195,425 -18.0% 1.60 US$311,879
2025-10-02 2025-09-30 S Sale
3.3
BAKER BROS. ADVISORS LP

Former 10% owner
21,376 -18.0%
1.60
US$34,114 		21,376 -18.0% 1.60 US$34,114
2025-06-26 2025-06-24 PlS Planned sale
3.6
Reumuth Mary

CHIEF FINANCIAL OFFICER

Officer
3,631 -5.5%
4.01
US$14,560 		3,631 -5.5% 4.01 US$14,560
2025-06-26 2025-06-24 PlS Planned sale
3.3
Brazzell Romulus K

SEE REMARKS

Officer
5,251 -6.0%
4.01
US$21,057 		5,251 -6.0% 4.01 US$21,057
2025-06-26 2025-06-24 PlS Planned sale
3.3
Iwicki Mark T
Non-Executive Director
13,227 -4.9%
4.01
US$53,040 		13,227 -4.9% 4.01 US$53,040
2025-06-26 2025-06-24 PlS Planned sale
2.3
Bazemore Todd

SEE REMARKS

Officer
4,058 -4.6%
4.01
US$16,273 		4,058 -4.6% 4.01 US$16,273
2025-06-26 2025-06-24 PlS Planned sale
3.3
Kharabi Darius

CHIEF BUSINESS OFFICER

Officer
4,511 -6.7%
4.01
US$18,089 		4,511 -6.7% 4.01 US$18,089
2025-06-24 2025-06-24 PrS Proposed sale
3.3
Mark T Iwicki

Director

Non-Executive Director
13,227
4.01
US$53,040 		13,227 4.01 US$53,040
2025-06-24 2025-06-24 PrS Proposed sale
2.3
Todd M Bazemore

Officer

Officer
4,058
4.01
US$16,273 		4,058 4.01 US$16,273
2025-06-24 2025-06-24 PrS Proposed sale
3.3
Romulus K Brazzell

Officer

Officer
5,251
4.01
US$21,057 		5,251 4.01 US$21,057
2025-06-24 2025-06-24 PrS Proposed sale
3.6
Mary Reumuth

Officer

Officer
3,631
4.01
US$14,560 		3,631 4.01 US$14,560
2025-06-24 2025-06-24 PrS Proposed sale
3.3
Darius Kharabi

Officer

Officer
4,511
4.01
US$18,089 		4,511 4.01 US$18,089
2025-06-04 2025-06-03 PlS Planned sale
2.3
Bazemore Todd

SEE REMARKS

Officer
3,390 -3.7%
3.74
US$12,679 		3,390 -3.7% 3.74 US$12,679
2025-06-04 2025-06-03 PlS Planned sale
3.3
Brazzell Romulus K

SEE REMARKS

Officer
3,687 -4.0%
3.74
US$13,789 		3,687 -4.0% 3.74 US$13,789
2025-06-04 2025-06-03 PlS Planned sale
3.6
Reumuth Mary

CHIEF FINANCIAL OFFICER

Officer
2,850 -4.2%
3.74
US$10,659 		2,850 -4.2% 3.74 US$10,659
2025-06-04 2025-06-03 PlS Planned sale
3.3
Kharabi Darius

CHIEF BUSINESS OFFICER

Officer
730 -1.1%
3.74
US$2,730 		730 -1.1% 3.74 US$2,730
2025-06-03 2025-06-03 PrS Proposed sale
3.3
Mark T Iwicki

Director

Non-Executive Director
10,866
3.74
US$40,639 		10,866 3.74 US$40,639
2025-01-07 2025-01-06 PlS Planned sale
3.6
Reumuth Mary

CHIEF FINANCIAL OFFICER

Officer
1,706 -2.4%
7.63
US$13,017 		1,706 -2.4% 7.63 US$13,017
2025-01-07 2025-01-06 PlS Planned sale
3.3
Kharabi Darius

CHIEF BUSINESS OFFICER

Officer
2,021 -2.9%
7.63
US$15,420 		2,021 -2.9% 7.63 US$15,420
2025-01-07 2025-01-06 PlS Planned sale
3.3
Brazzell Romulus K

SEE REMARKS

Officer
2,446 -2.6%
7.63
US$18,663 		2,446 -2.6% 7.63 US$18,663
2025-01-07 2025-01-06 PlS Planned sale
3.3
Iwicki Mark T

CHIEF EXECUTIVE OFFICER

Executive Director
5,779 -2.0%
7.63
US$44,094 		5,779 -2.0% 7.63 US$44,094
2025-01-06 2025-01-06 PrS Proposed sale
3.3
Mark T Iwicki

Officer; Director

Executive Director
5,779
7.63
US$44,079 		5,779 7.63 US$44,079
2024-12-31 2024-12-30 B Purchase
3.3
BAKER BROS. ADVISORS LP
Large shareholder
279,939 +34.8%
6.44
US$1,802,807 		279,939 +34.8% 6.44 US$1,802,807
2024-12-31 2024-12-30 B Purchase
3.3
BAKER BROS. ADVISORS LP
Large shareholder
30,620 +34.8%
6.44
US$197,193 		30,620 +34.8% 6.44 US$197,193
2024-07-17 2024-07-17 PrS Proposed sale
Trachtenberg Eric

Officer

Officer
3,917
7.80
US$30,553 		3,917 7.80 US$30,553
2024-07-16 2024-07-16 PrS Proposed sale
Trachtenberg Eric

Officer

Officer
1,281
7.64
US$9,788 		1,281 7.64 US$9,788
2024-06-27 2024-06-26 PlS Planned sale
3.3
Iwicki Mark T

CHIEF EXECUTIVE OFFICER

Executive Director
15,168 -5.4%
4.75
US$72,048 		15,168 -5.4% 4.75 US$72,048
2024-06-27 2024-06-26 PlS Planned sale
3.6
Reumuth Mary

CHIEF FINANCIAL OFFICER

Officer
4,163 -6.5%
4.75
US$19,774 		4,163 -6.5% 4.75 US$19,774
2024-06-27 2024-06-26 PlS Planned sale
2.3
Bazemore Todd

SEE REMARKS

Officer
4,653 -5.3%
4.75
US$22,102 		4,653 -5.3% 4.75 US$22,102
2024-06-27 2024-06-26 PlS Planned sale
3.3
Kharabi Darius

CHIEF BUSINESS OFFICER

Officer
5,158 -7.9%
4.75
US$24,500 		5,158 -7.9% 4.75 US$24,500
2024-06-27 2024-06-26 PlS Planned sale
3.3
Brazzell Romulus K

SEE REMARKS

Officer
5,489 -6.1%
4.75
US$26,073 		5,489 -6.1% 4.75 US$26,073
2024-06-24 2024-06-24 PrS Proposed sale
2.3
Todd M Bazemore

Officer

Officer
4,356
4.90
US$21,342 		4,356 4.90 US$21,342
2024-06-24 2024-06-24 PrS Proposed sale
3.3
Darius Kharabi

Officer

Officer
4,830
4.90
US$23,662 		4,830 4.90 US$23,662
2024-06-24 2024-06-24 PrS Proposed sale
3.6
Mary Reumuth

Officer

Officer
3,897
4.90
US$19,092 		3,897 4.90 US$19,092
2024-06-24 2024-06-24 PrS Proposed sale
3.3
Mark T Iwicki

Officer; Director

Executive Director
14,210
4.90
US$69,627 		14,210 4.90 US$69,627
2024-06-24 2024-06-24 PrS Proposed sale
3.3
Romulus K Brazzell

Officer

Officer
5,140
4.90
US$25,183 		5,140 4.90 US$25,183
2024-06-03 2024-05-31 PlS Planned sale
3.3
Kharabi Darius

CHIEF BUSINESS OFFICER

Officer
231 -0.4%
6.09
US$1,407 		231 -0.4% 6.09 US$1,407
2024-06-03 2024-05-31 PlS Planned sale
3.3
Iwicki Mark T

CHIEF EXECUTIVE OFFICER

Executive Director
7,392 -2.6%
6.09
US$45,017 		7,392 -2.6% 6.09 US$45,017
2024-06-03 2024-05-31 PlS Planned sale
3.3
Brazzell Romulus K

SEE REMARKS

Officer
2,002 -2.2%
6.09
US$12,192 		2,002 -2.2% 6.09 US$12,192
2024-06-03 2024-05-31 PlS Planned sale
2.3
Bazemore Todd

SEE REMARKS

Officer
2,093 -2.3%
6.09
US$12,746 		2,093 -2.3% 6.09 US$12,746
2024-06-03 2024-05-31 PlS Planned sale
3.6
Reumuth Mary

CHIEF FINANCIAL OFFICER

Officer
1,786 -2.7%
6.09
US$10,877 		1,786 -2.7% 6.09 US$10,877
2024-05-31 2024-05-31 PrS Proposed sale
3.3
Mark T Iwicki

Officer; Director

Executive Director
7,392
6.09
US$45,031 		7,392 6.09 US$45,031
2024-01-05 2024-01-04 PlS Planned sale
3.3
Brazzell Romulus K

SEE REMARKS

Officer
1,617 -1.7%
6.74
US$10,899 		1,617 -1.7% 6.74 US$10,899
2024-01-05 2024-01-04 PlS Planned sale
Trachtenberg Eric

SEE REMARKS

Officer
1,227 -1.8%
6.74
US$8,270 		1,227 -1.8% 6.74 US$8,270
2024-01-05 2024-01-04 PlS Planned sale
3.6
Reumuth Mary

CHIEF FINANCIAL OFFICER

Officer
1,227 -1.8%
6.74
US$8,270 		1,227 -1.8% 6.74 US$8,270
2024-01-05 2024-01-04 PlS Planned sale
3.3
Kharabi Darius

CHIEF BUSINESS OFFICER

Officer
1,385 -2.1%
6.73
US$9,321 		1,385 -2.1% 6.73 US$9,321
2024-01-05 2024-01-04 PlS Planned sale
3.3
Iwicki Mark T

CHIEF EXECUTIVE OFFICER

Executive Director
4,539 -1.6%
6.73
US$30,547 		4,539 -1.6% 6.73 US$30,547
2023-01-06 2023-01-04 PlS Planned sale
3.3
Brazzell Romulus K

SEE REMARKS

Officer
73 -0.4%
28.53
US$2,083 		73 -0.4% 28.53 US$2,083
2023-01-06 2023-01-04 PlS Planned sale
3.6
Reumuth Mary

CHIEF FINANCIAL OFFICER

Officer
60 -0.5%
28.54
US$1,712 		60 -0.5% 28.54 US$1,712
2023-01-06 2023-01-04 PlS Planned sale
3.3
Iwicki Mark T

CHIEF EXECUTIVE OFFICER

Executive Director
198 -0.4%
28.54
US$5,651 		198 -0.4% 28.54 US$5,651
2023-01-06 2023-01-04 PlS Planned sale
2.3
Bazemore Todd

SEE REMARKS

Officer
62 -0.4%
28.54
US$1,769 		62 -0.4% 28.54 US$1,769
2023-01-06 2023-01-04 PlS Planned sale
Trachtenberg Eric

SEE REMARKS

Officer
60 -0.5%
28.55
US$1,713 		60 -0.5% 28.55 US$1,713
2022-10-28 2022-10-26 PlS Planned sale
3.3
Iwicki Mark T

CHIEF EXECUTIVE OFFICER

Executive Director
561 -11.2%
6.52
US$3,658 		561 -11.2% 6.52 US$3,658
2022-10-28 2022-10-26 PlS Planned sale
2.3
Bazemore Todd

SEE REMARKS

Officer
214 -9.3%
6.51
US$1,393 		214 -9.3% 6.51 US$1,393
2022-10-28 2022-10-26 PlS Planned sale
3.3
Brazzell Romulus K

SEE REMARKS

Officer
261 -4.3%
6.51
US$1,699 		261 -4.3% 6.51 US$1,699
2022-10-28 2022-10-26 PlS Planned sale
3.6
Reumuth Mary

CHIEF FINANCIAL OFFICER

Officer
194 -7.4%
6.51
US$1,263 		194 -7.4% 6.51 US$1,263
2022-10-28 2022-10-26 PlS Planned sale
Trachtenberg Eric

SEE REMARKS

Officer
194 -8.7%
6.52
US$1,265 		194 -8.7% 6.52 US$1,265
2022-06-29 2022-06-27 PlS Planned sale
3.3
Iwicki Mark T

CHIEF EXECUTIVE OFFICER

Executive Director
7,975 -3.1%
0.37
US$2,951 		7,975 -3.1% 0.37 US$2,951
Explore more

More insider trading research around KALA BIO Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America